Extended use of orlistat and sibutramine

被引：0
|
作者：
不详
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 82卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：8 / 9
页数：2
相关论文
共 50 条
  • [31] Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients
    Derosa, G
    Cicero, AFG
    Murdolo, G
    Ciccarelli, L
    Fogari, R
    DIABETES NUTRITION & METABOLISM, 2004, 17 (04) : 222 - 229
  • [32] The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions
    Coutinho, Walmir
    ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA, 2009, 53 (02) : 262 - 270
  • [33] New antiobesity agents in type 2 diabetes: Overview of clinical trials with sibutramine and orlistat
    Scheen, AJ
    Ernest, PH
    DIABETES & METABOLISM, 2002, 28 (06) : 437 - 445
  • [34] Efficacy and Tolerability of the Association of Sibutramine and Orlistat for Six Months in Over weight and Obese Patients
    Halpern, Alfredo
    Pepe, Renata B.
    Monegaglia, Ana Paola
    Beyruti, Monica
    de Melo, Maria Edna
    Mancini, Marcio C.
    JOURNAL OF OBESITY, 2010, 2010
  • [35] The safety profiles of orlistat and sibutramine: Results of prescription-event monitoring studies in England
    Perrio, Michael J.
    Wilton, Lynda V.
    Shakir, Saad A. W.
    OBESITY, 2007, 15 (11) : 2712 - 2722
  • [36] Currently available drugs for the treatment of obesity: Sibutramine and orlistat (vol 7, pg 3, 2007)
    Chaput, J. P.
    St-Pierre, S.
    Tremblay, A.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2009, 9 (02) : 272 - 272
  • [37] NPY5R antagonism does not augment the weight loss efficacy of orlistat or sibutramine
    Erondu, Ngozi
    Addy, Carol
    Lu, Kaifeng
    Mallick, Madhuja
    Musser, Bret
    Gantz, Ira
    Proietto, Joseph
    Astrup, Arne
    Toubro, Soren
    Rissannen, Aila M.
    Tonstad, Serena
    Haynes, William G.
    Gottesdiener, Keith M.
    Kaufman, Keith D.
    Amatruda, John M.
    Heymsfield, Steven B.
    OBESITY, 2007, 15 (08) : 2027 - 2042
  • [38] Efficacy of sibutramine, orlistat and combination therapy on short-term weight management in obese patients
    Kaya, A
    Aydin, N
    Topsever, P
    Filiz, M
    Öztürk, A
    Dagar, A
    Kilinç, E
    Ekmekcioglu, C
    BIOMEDICINE & PHARMACOTHERAPY, 2004, 58 (10) : 582 - 587
  • [39] Use of sibutramine to treat obesity
    Ryan, DH
    PRIMARY CARE, 2003, 30 (02): : 405 - +
  • [40] Comparison of orlistat and sibutramine in an obesity management program: Efficacy compliance, and weight regain after noncompliance
    Gursoy A.
    Erdogan M.F.
    Cin M.O.
    Cesur M.
    Baskal N.
    Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity, 2006, 11 (4) : e127 - e132
12345